Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ICU is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
5 top institutions tracked
Sentiment: neutral
Last trade: buy 56 days ago
Red flags: 5
18 filers reported a long position in ICU for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $182K | 49.6K | -10.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | $121.4K | 33.1K | +14.9% |
| UBS Group AG | $115.2K | 31.4K | +3,859.4% |
| VANGUARD FIDUCIARY TRUST CO | $50.3K | 13.7K | Unchanged |
| JANE STREET GROUP, LLC | $46.4K | 12.6K | -54.8% |
| NORTHERN TRUST CORP | $38.2K | 10.4K | New |
| Tower Research Capital LLC (TRC) | $5K | 1.4K | -2.8% |
| BlackRock, Inc. | $3.4K | 913 | Unchanged |
| OSAIC HOLDINGS, INC. | $714 | 195 | -15.2% |
| NewEdge Advisors, LLC | $647 | 176 | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.